Publications by authors named "Samridhi Dhyani"

Article Synopsis
  • New variants of SARS-CoV-2 highlight the need for effective treatments, leading to the discovery of a powerful monoclonal antibody called P4A2 that neutralizes all current variants, including Omicron.!
  • The structure of the P4A2 antibody reveals that its target on the virus's spike protein remains unchanged across different variants, ensuring its effectiveness against circulating strains.!
  • Testing in mice shows that administering P4A2 can protect against infections from these variants, suggesting significant therapeutic potential for future SARS-CoV-2 variants as well.!
View Article and Find Full Text PDF

Numerous human pathogens, especially Gram-negative bacteria, are able to enter the viable-but-non-culturable (VBNC) state when they are exposed to environmental stressors and pose the risk of being resuscitated and causing infection after the removal of the trigger. Widely used food preservatives like weak organic acids are potential VBNC inducers in food processing and packaging facilities but have only been reported for food-borne pathogens. In the present study, it is demonstrated for the first time that one such agent, formic acid (FA), can induce a VBNC state at food processing, storage, and distribution temperatures (4, 25, and 37C) with a varied time of treatment (days 4-10) in pathogenic Gram-negative bacteria and .

View Article and Find Full Text PDF
Article Synopsis
  • * Binding studies indicate that II62 effectively interacts with various SARS-CoV-2 variants without disrupting the virus's ability to bind to the ACE2 receptor.
  • * Neutralization tests show that increasing the antibody's valency from monovalent to tetravalent does not negatively affect its interaction with host cells in virus testing assays.
View Article and Find Full Text PDF

Phage display is a proven and widely used technology for selecting specific antibodies against desired targets. However, an immense amount of effort is required to identify and screen the desired positive clones from large and diverse combinatorial libraries. On the other hand, the selection of positive binding clones from synthetic and semi-synthetic libraries has an inherent bias toward clones with randomly produced amber stop codons, making it more difficult to identify desirable binding antibodies.

View Article and Find Full Text PDF